Plasma GBP2 promoter methylation is associated with advanced stages in breast cancer

Blood methylated cell-free DNA (cfDNA) as a minimally invasive cancer biomarker has great importance in cancer management. Guanylate binding protein 2 (GBP2) has been considered as a possible controlling factor in tumor development. GBP2 gene expression and its promoter methylation status in both pl...

Descripción completa

Detalles Bibliográficos
Autores principales: Rahvar, Farzaneh, Salimi, Mahdieh, Mozdarani, Hossein
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Genética 2020
Materias:
Human and Medical Genetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7783727/
https://www.ncbi.nlm.nih.gov/pubmed/33211060
http://dx.doi.org/10.1590/1678-4685-GMB-2019-0230

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7783727/
https://www.ncbi.nlm.nih.gov/pubmed/33211060
http://dx.doi.org/10.1590/1678-4685-GMB-2019-0230

Ejemplares similares